| Abigail Seiger, SLP | |
|
3160 N Arizona Ave, Chandler, AZ 85225-7122 | |
| (480) 365-9981 | |
| Not Available |
| Full Name | Abigail Seiger |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3160 N Arizona Ave, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285937920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | TSLP7063 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Abigail Seiger, SLP 2147 E Virginia Ave, Phoenix, AZ 85006-1345 Ph: (602) 295-4149 | Abigail Seiger, SLP 3160 N Arizona Ave, Chandler, AZ 85225-7122 Ph: (480) 365-9981 |
News Archive
A new study published in the journal Nature Climate Change on November 25, 2019, says that women may be unable to change their mode of survival to adapt to climate change and resulting alterations in socioeconomic and cultural conditions. The factors responsible for this difficulty may include migration of male family members and unfavourable working conditions, abetted by governmental failure to support them, or poverty.
Classic psychedelics, such as LSD, psilocybin mushrooms and mescaline, previously have been shown to occasion lasting improvements in mental health. But researchers led by University of Alabama at Birmingham School of Public Health investigators wanted to advance the existing research and determine whether classic psychedelics might be protective with regard to suicidal thoughts.
There is growing evidence that adipose tissue plays a key role in the aggravation of COVID-19. One of the theories under investigation is that fat cells (adipocytes) act as a reservoir for SARS-CoV-2 and increase viral load in obese or overweight individuals.
Charles L. Saltzman, MD, newly-elected president of the American Orthopaedic Foot & Ankle Society (AOFAS), presented the results of a groundbreaking study at the recent AOFAS 2009 Annual Summer Meeting in Vancouver, British Columbia, Canada.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs, announced today that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton's tyrosine kinase (Btk). AVL-292 is the first product candidate to enter clinical evaluation from Avila's proprietary covalent drug platform, Avilomics™.
› Verified 4 days ago
Ms. Heather Marie Liu, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6543 S Teresa Dr, Chandler, AZ 85249 Phone: 480-329-7600 | |
Allison Dawn Smith, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 815 E Warner Rd, Suite 106, Chandler, AZ 85225 Phone: 480-963-5800 Fax: 480-963-5805 | |
Miss Demaurice Jiana Basile, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Alicia Rowlett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3400 N Alma School Rd Apt 2034, Chandler, AZ 85224 Phone: 719-671-7172 | |
Gail Cisneros, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Gabrielle Christine Goldsmith, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 964 E Cherry Hills Dr, Chandler, AZ 85249 Phone: 509-217-3367 | |
Lauren Mead, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 |